Penile scarring with intracavernous injection therapy using prostaglandin E1: A risk factor analysis

Journal of Urology

Volumn 155, Issue 1, 1996, Pages 138-140

  Chen, Roland N ^a   Lakin, Milton M ^a   Montague, Drogo K ^a   Ausmundson, Sandy ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Alprostadil; Cicatrix; Impotence; Penile erection; Prostaglandins E

Indexed keywords

PROSTAGLANDIN E1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG ADMINISTRATION; HUMAN; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; PENIS DISEASE; PRIORITY JOURNAL; RISK FACTOR; SCAR;

ALPROSTADIL; CASE-CONTROL STUDIES; CICATRIX; COMPARATIVE STUDY; HUMAN; IMPOTENCE; IMPOTENCE, VASCULOGENIC; INCIDENCE; INJECTIONS; MALE; MIDDLE AGE; PENILE ERECTION; PENIS; RISK FACTORS; SELF ADMINISTRATION; VASODILATOR AGENTS;

EID: 0029656220     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66574-1     Document Type: Article

References (6)

1. Hu, K.-N., Burks, C. and Christy, W. C.: Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection. J. Urol., 138: 404, 1987.
2. Larsen, E. H., Gasser, T. C. and Bruskewitz, R. C.: Fibrosis of corpus cavernosum after intracavernous injection of phentolamine/papaverine. J. Urol., 137: 292, 1987.
3. Fuchs, M. E. and Brawer, M. K.: Papaverine-induced fibrosis of the corpus cavernosum. J. Urol., 141: 125, 1989.
4. Lakin, M. M., Montague, D. K., Medendorp, S. V., Tesar, L. and Schover, L. R.: Intracavernous injection therapy: analysis of results and complications. J. Urol., 143: 1138, 1990.
5. Gerber, G. S. and Levine, L. A.: Pharmacological erection program using prostaglandin E1. J. Urol., 146: 786, 1991.
6. Levine, S. B., Althof, S. E., Turner, L. A., Risen, C. B., Bodner, D. B., Kursh, E. D. and Resnick, M. I.: Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. J. Urol., 141: 54, 1989.